Skip to content

Trospium

Published: July 26, 2026Updated: July 26, 2026

Trospium is a muscarinic antagonist medication used to treat overactive bladder and urinary incontinence. It works by blocking acetylcholine receptors in the bladder, which reduces involuntary muscle contractions and decreases the urgency and frequency of urination.

Quick summary

Trospium is an anticholinergic bladder medication that reduces urinary urgency and frequency by relaxing bladder smooth muscle.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
G04BD09
RxNorm
236778
Generic
Trospium
Class
atc-g04
Brands
Cobenfy
Availability
rx
Pregnancy
C
Lactation
caution
Routes
oral
Forms
capsule, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious anticholinergic toxicity in adults
Chronic overdose: cumulative toxicity from repeated supratherapeutic doses exceeding recommended daily limits over extended period
Immediate actions
supportive care, gastric decontamination if within 1-2 hours of ingestion, airway management, cardiac monitoring
Antidote
physostigmine(may be considered for severe anticholinergic toxicity; use with caution due to risk of cholinergic crisis and cardiac complications)
Poison Control: 1-800-222-1222

Special Populations

8 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh potential risks to fetus

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

continue only if benefits outweigh risks

Monitor

routine prenatal care

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid close to delivery

Key Recommendations

discontinue before delivery if possible

Monitor

fetal monitoring

Use with caution and monitor for adverse effects.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

discontinue or switch formula

Key Recommendations

not recommended during breastfeeding due to excretion in breast milk

Monitor

infant monitoring for anticholinergic effects

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start with low dose

Key Recommendations

use with caution due to increased sensitivity to anticholinergic effects and cognitive impairment risk

Monitor

monitor cognitive function and anticholinergic side effects

Use with caution and monitor for adverse effects.

✗

pediatric_age

children adolescents
unsafe
FDA Category
C
Dose Adjustment

not recommended

Key Recommendations

not approved for use in patients under 18 years

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

severe renal impairment
caution
FDA Category
C
Dose Adjustment

reduce dose to 20mg once daily

Key Recommendations

dose reduction required in severe renal impairment (CrCl<30mL/min)

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate hepatic impairment
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

use cautiously in moderate hepatic impairment

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2024

FDA approval year

Value:2004

Original FDA approval for overactive bladder

drug_classFDA
2024

Drug class

Value:Muscarinic antagonist (anticholinergic)

Pharmacological classification

usageFDA
2024

Common uses

Value:Overactive bladder, Schizophrenia (Cobenfy)

Therapeutic indications

mechanismFDA
2024

Mechanism of action

Value:Muscarinic M3 receptor antagonist

Pharmacodynamic mechanism

Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Trospium chloride antagonizes acetylcholine at muscarinic receptors in the bladder, reducing parasympathetic stimulation and decreasing detrusor muscle contractility, which lowers bladder pressure and increases bladder capacity.

Common side effects include dry mouth, constipation, and blurred vision. Use with caution in patients with narrow-angle glaucoma, urinary retention, or severe gastrointestinal conditions. May cause drowsiness; avoid driving until effects are known.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy